Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function

NCT00981045 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2561

Enrollment

INDUSTRY

Sponsor class

Conditions

Iron Deficiency Anemia
Impaired Renal Function

Interventions

DRUG: Ferric Carboxymaltose (FCM)
DRUG: Iron Sucrose (Venofer)

Sponsor

American Regent, Inc.